Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Grønbæk H[au]:

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Kazankov K et al. Nat Rev Gastroenterol Hepatol. (2019)

Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. Raaby L et al. Acta Derm Venereol. (2017)

[Acute-on-chronic liver failure]. Ørntoft NW et al. Ugeskr Laeger. (2017)

Search results

Items: 1 to 50 of 260

1.

Prospective study of chromogranin A as a predictor of progression in patients with pancreatic, small intestinal and unknown primary neuroendocrine tumors.

Dam G, Grønbæk H, Sorbye H, Thiis Evensen E, Paulsson B, Sundin A, Jensen C, Ebbesen D, Knigge U, Tiensuu Janson E.

Neuroendocrinology. 2019 Oct 2. doi: 10.1159/000503833. [Epub ahead of print]

PMID:
31578011
2.

Time-dependent improvement of liver inflammation, fibrosis and metabolic liver function after successful direct-acting antiviral therapy of chronic hepatitis C.

Laursen TL, Siggaard CB, Kazankov K, Sandahl TD, Møller HJ, Tarp B, Kristensen LH, Laursen AL, Leutscher P, Grønbaek H.

J Viral Hepat. 2019 Sep 10. doi: 10.1111/jvh.13204. [Epub ahead of print]

PMID:
31502741
3.

Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis.

Fernández J, Angeli P, Trebicka J, Merli M, Gustot T, Alessandria C, Aagaard NK, de Gottardi A, Welzel TM, Gerbes A, Soriano G, Vargas V, Albillos A, Salerno F, Durand F, Bañares R, Stauber R, Prado V, Arteaga M, Hernández-Tejero M, Aziz F, Morando F, Jansen C, Lattanzi B, Moreno C, Campion D, Gronbaek H, Garcia R, Sánchez C, García E, Amorós A, Pavesi M, Clària J, Moreau R, Arroyo V.

Clin Gastroenterol Hepatol. 2019 Aug 5. pii: S1542-3565(19)30844-4. doi: 10.1016/j.cgh.2019.07.055. [Epub ahead of print]

PMID:
31394283
4.

Use of biologically based complementary medicines in patients with neuroendocrine tumors.

Borre M, Dam GA, Grønbaek H.

Scand J Gastroenterol. 2019 Aug;54(8):998-1002. doi: 10.1080/00365521.2019.1646799. Epub 2019 Aug 1.

PMID:
31368373
5.

The Macrophage Activation Marker Soluble CD163 is Associated With Early Allograft Dysfunction After Liver Transplantation.

Thomsen KL, Robertson FP, Holland-Fischer P, Davidson BR, Mookerjee RP, Møller HJ, Jalan R, Grønbæk H.

J Clin Exp Hepatol. 2019 May-Jun;9(3):302-311. doi: 10.1016/j.jceh.2018.09.006. Epub 2018 Oct 5.

PMID:
31360022
6.

Effects of glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, on markers of liver status in patients with short bowel syndrome: findings from a randomised phase 2 trial.

Naimi RM, Hvistendahl M, Nerup N, Ambrus R, Achiam MP, Svendsen LB, Grønbæk H, Møller HJ, Vilstrup H, Steensberg A, Jeppesen PB.

EBioMedicine. 2019 Aug;46:444-451. doi: 10.1016/j.ebiom.2019.07.016. Epub 2019 Jul 17.

7.

Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.

Rosso C, Kazankov K, Younes R, Esmaili S, Marietti M, Sacco M, Carli F, Gaggini M, Salomone F, Møller HJ, Abate ML, Vilstrup H, Gastaldelli A, George J, Grønbæk H, Bugianesi E.

J Hepatol. 2019 Nov;71(5):1012-1021. doi: 10.1016/j.jhep.2019.06.031. Epub 2019 Jul 10.

PMID:
31301321
8.

The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms.

Nielsen MC, Andersen MN, Rittig N, Rødgaard-Hansen S, Grønbaek H, Moestrup SK, Møller HJ, Etzerodt A.

J Leukoc Biol. 2019 Nov;106(5):1129-1138. doi: 10.1002/JLB.3A1218-500R. Epub 2019 Jun 26.

PMID:
31242338
9.

Non-alcoholic steatohepatitis, but not simple steatosis, disturbs the functional homogeneity of the liver - a human galactose positron emission tomography study.

Eriksen PL, Thomsen KL, Larsen LP, Grønbaek H, Vilstrup H, Sørensen M.

Aliment Pharmacol Ther. 2019 Jul;50(1):84-92. doi: 10.1111/apt.15293. Epub 2019 May 17.

PMID:
31099410
10.

Macrophage markers soluble CD163 and soluble mannose receptor are associated with liver injury in patients with paracetamol overdose.

Siggaard CB, Kazankov K, Rødgaard-Hansen S, Møller HJ, Donnelly MC, Simpson KJ, Grønbaek H.

Scand J Gastroenterol. 2019 May;54(5):623-632. doi: 10.1080/00365521.2019.1608292. Epub 2019 May 8.

PMID:
31067143
11.

Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease.

Sundelin EIO, Gormsen LC, Heebøll S, Vendelbo MH, Jakobsen S, Munk OL, Feddersen S, Brøsen K, Hamilton-Dutoit SJ, Pedersen SB, Grønbaek H, Jessen N.

Br J Clin Pharmacol. 2019 Aug;85(8):1761-1770. doi: 10.1111/bcp.13962. Epub 2019 Jun 18.

PMID:
30973968
12.

Effects of implementation of a national fast track clinical pathway for hepatocellular carcinoma in Western Denmark.

Villadsen GE, Simonsen K, Ott P, Vilstrup H, Grønbæk H.

J Gastrointestin Liver Dis. 2019 Mar;28(1):83-88. doi: 10.15403/jgld.2014.1121.281.dnk.

13.

Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects.

Laursen TL, Hagemann CA, Wei C, Kazankov K, Thomsen KL, Knop FK, Grønbæk H.

World J Hepatol. 2019 Feb 27;11(2):138-149. doi: 10.4254/wjh.v11.i2.138. Review.

14.

Non-alcoholic fatty liver disease causes dissociated changes in metabolic liver functions.

Lykke Eriksen P, Sørensen M, Grønbæk H, Hamilton-Dutoit S, Vilstrup H, Thomsen KL.

Clin Res Hepatol Gastroenterol. 2019 Oct;43(5):551-560. doi: 10.1016/j.clinre.2019.01.001. Epub 2019 Feb 13.

PMID:
30770336
15.

Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.

Suppli MP, Rigbolt KTG, Veidal SS, Heebøll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Oró D, Thrane SW, Lund A, Strandberg C, Kønig MJ, Vilsbøll T, Vrang N, Thomsen KL, Grønbæk H, Jelsing J, Hansen HH, Knop FK.

Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.

PMID:
30653341
16.

The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.

Kalledsøe L, Dragsted LO, Hansen L, Kyrø C, Grønbæk H, Tjønneland A, Olsen A.

Growth Horm IGF Res. 2019 Feb;44:33-42. doi: 10.1016/j.ghir.2018.12.003. Epub 2018 Dec 20.

PMID:
30622040
17.

[Christmas Article. String-mounted nameplates increase the risk of misidentification of doctors].

Christensen AK, Grønbæk H, Jepsen P.

Ugeskr Laeger. 2018 Dec 10;180(50). pii: V70276. Danish.

PMID:
30547867
18.

Orchestration of Tryptophan-Kynurenine Pathway, Acute Decompensation, and Acute-on-Chronic Liver Failure in Cirrhosis.

Clària J, Moreau R, Fenaille F, Amorós A, Junot C, Gronbaek H, Coenraad MJ, Pruvost A, Ghettas A, Chu-Van E, López-Vicario C, Oettl K, Caraceni P, Alessandria C, Trebicka J, Pavesi M, Deulofeu C, Albillos A, Gustot T, Welzel TM, Fernández J, Stauber RE, Saliba F, Butin N, Colsch B, Moreno C, Durand F, Nevens F, Bañares R, Benten D, Ginès P, Gerbes A, Jalan R, Angeli P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL Clif Consortium, Grifols Chair and the European Foundation for the Study of Chronic Liver Failure (EF Clif).

Hepatology. 2019 Apr;69(4):1686-1701. doi: 10.1002/hep.30363. Epub 2019 Mar 19.

PMID:
30521097
19.

The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Kazankov K, Jørgensen SMD, Thomsen KL, Møller HJ, Vilstrup H, George J, Schuppan D, Grønbæk H.

Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159. doi: 10.1038/s41575-018-0082-x. Review.

PMID:
30482910
20.

High hepatic macrophage activation and low liver function in stable Wilson patients - a Danish cross-sectional study.

Björklund J, Laursen TL, Sandahl TD, Møller HJ, Vilstrup H, Ott P, Grønbæk H.

Orphanet J Rare Dis. 2018 Sep 21;13(1):169. doi: 10.1186/s13023-018-0910-7.

21.

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial.

Kimer N, Gudmann NS, Pedersen JS, Møller S, Nielsen MJ, Leeming DJ, Karsdal MA, Møller HJ, Bendtsen F, Grønbæk H.

PLoS One. 2018 Sep 5;13(9):e0203200. doi: 10.1371/journal.pone.0203200. eCollection 2018.

22.

The role of IFN in the development of NAFLD and NASH.

Møhlenberg M, Terczynska-Dyla E, Thomsen KL, George J, Eslam M, Grønbæk H, Hartmann R.

Cytokine. 2019 Dec;124:154519. doi: 10.1016/j.cyto.2018.08.013. Epub 2018 Aug 21.

PMID:
30139548
23.

The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.

Stemann Lau T, Dam G, Jepsen P, Grønbæk H, Krogh K, Gregersen T.

Neuroendocrinology. 2018;107(3):280-283. doi: 10.1159/000492786. Epub 2018 Aug 9.

PMID:
30092588
24.

Macrophage Markers Are Poorly Associated With Liver Histology in Children With Nonalcoholic Fatty Liver Disease.

Kazankov K, Alisi A, Møller HJ, De Vito R, Rittig S, Mahler B, Nobili V, Grønbæk H.

J Pediatr Gastroenterol Nutr. 2018 Nov;67(5):635-642. doi: 10.1097/MPG.0000000000002111.

PMID:
30074574
25.

[Treatment of non-alcoholic fatty liver disease].

Heebøll S, Vilstrup H, Grønbæk H.

Ugeskr Laeger. 2018 Jul 30;180(31). pii: V12170933. Review. Danish.

PMID:
30064623
26.

Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.

Hernández-Gea V, Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Martinez J, Genescà J, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Abraldes JG, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC; International Variceal Bleeding Observational Study Group and Baveno Cooperation.

Hepatology. 2019 Jan;69(1):282-293. doi: 10.1002/hep.30182. Epub 2018 Dec 10.

27.

β-Blockers Improve Presinusoidal Portal Hypertension.

Sørensen M, Larsen LP, Villadsen GE, Aagaard NK, Grønbæk H, Keiding S, Vilstrup H.

Dig Dis Sci. 2018 Nov;63(11):3153-3157. doi: 10.1007/s10620-018-5186-1. Epub 2018 Jul 12.

28.

Rapid and persistent decline in soluble CD163 with successful direct-acting antiviral therapy and associations with chronic hepatitis C histology.

Lund Laursen T, Brøckner Siggard C, Kazankov K, Damgaard Sandahl T, Møller HJ, Ong A, Douglas MW, George J, Tarp B, Hagelskjaer Kristensen L, Lund Laursen A, Hiramatsu A, Nakahara T, Chayama K, Grønbaek H.

Scand J Gastroenterol. 2018 Aug;53(8):986-993. doi: 10.1080/00365521.2018.1481996. Epub 2018 Jul 10.

PMID:
29987961
29.

Urea cycle dysregulation in non-alcoholic fatty liver disease.

De Chiara F, Heebøll S, Marrone G, Montoliu C, Hamilton-Dutoit S, Ferrandez A, Andreola F, Rombouts K, Grønbæk H, Felipo V, Gracia-Sancho J, Mookerjee RP, Vilstrup H, Jalan R, Thomsen KL.

J Hepatol. 2018 Oct;69(4):905-915. doi: 10.1016/j.jhep.2018.06.023. Epub 2018 Jul 5.

PMID:
29981428
30.

No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.

Poulsen MK, Nellemann B, Bibby BM, Stødkilde-Jørgensen H, Pedersen SB, Grønbaek H, Nielsen S.

Diabetes Obes Metab. 2018 Oct;20(10):2504-2509. doi: 10.1111/dom.13409. Epub 2018 Jul 5.

PMID:
29885082
31.

Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis.

Svart M, Rittig N, Møller N, Møller HJ, Gronbaek H.

J Diabetes Investig. 2019 Jan;10(1):67-72. doi: 10.1111/jdi.12869. Epub 2018 Jun 30.

32.

[New name and new treatments for primary biliary cholangitits].

Bossen L, Ytting H, Jepsen P, Hamberg O, Ott P, Grønbæk H.

Ugeskr Laeger. 2018 Mar 5;180(10). pii: V07170531. Review. Danish.

PMID:
29536837
33.

Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease.

Christensen CU, Glavind E, Thomsen KL, Kim YO, Heebøll S, Schuppan D, Hamilton-Dutoit S, Würtz Heegaard C, Grønbæk H.

PLoS One. 2018 Mar 9;13(3):e0192728. doi: 10.1371/journal.pone.0192728. eCollection 2018.

34.

Adult Presentation of Noncirrhotic Portal Hypertension and Ascites following Treatment for Wilms' Tumor in Childhood.

Kievit L, Kræmer P, Hamilton-Dutoit S, Grønbæk H.

Case Rep Gastroenterol. 2018 Feb 1;12(1):56-62. doi: 10.1159/000486389. eCollection 2018 Jan-Apr.

35.

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3).

Ali AS, Grönberg M, Langer SW, Ladekarl M, Hjortland GO, Vestermark LW, Österlund P, Welin S, Grønbæk H, Knigge U, Sorbye H, Janson ET.

Med Oncol. 2018 Mar 6;35(4):47. doi: 10.1007/s12032-018-1103-x.

36.

Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis.

Haldrup D, Heebøll S, Thomsen KL, Andersen KJ, Meier M, Mortensen FV, Nyengaard JR, Hamilton-Dutoit S, Grønbæk H.

World J Hepatol. 2018 Jan 27;10(1):8-21. doi: 10.4254/wjh.v10.i1.8.

37.

Nutritional status and nutritional risk in patients with neuroendocrine tumors.

Borre M, Dam GA, Knudsen AW, Grønbaek H.

Scand J Gastroenterol. 2018 Mar;53(3):284-292. doi: 10.1080/00365521.2018.1430848. Epub 2018 Jan 26.

PMID:
29373941
38.

Unexplained cholestasis in adults and adolescents: diagnostic benefit of genetic examination.

Aamann L, Ørntoft N, Vogel I, Grønbaek H, Becher N, Vilstrup H, Ott P, Lildballe DL.

Scand J Gastroenterol. 2018 Mar;53(3):305-311. doi: 10.1080/00365521.2017.1422800. Epub 2018 Jan 5.

PMID:
29304564
39.

Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial.

Rittig N, Svart M, Jessen N, Møller N, Møller HJ, Grønbæk H.

Endocr Connect. 2018 Jan;7(1):107-114. doi: 10.1530/EC-17-0296.

40.

Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.

Rainer F, Horvath A, Sandahl TD, Leber B, Schmerboeck B, Blesl A, Groselj-Strele A, Stauber RE, Fickert P, Stiegler P, Møller HJ, Grønbaek H, Stadlbauer V.

Aliment Pharmacol Ther. 2018 Mar;47(5):657-664. doi: 10.1111/apt.14474. Epub 2017 Dec 21.

41.

The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.

Sandahl TD, Støy SH, Laursen TL, Rødgaard-Hansen S, Møller HJ, Møller S, Vilstrup H, Grønbæk H.

PLoS One. 2017 Dec 13;12(12):e0189345. doi: 10.1371/journal.pone.0189345. eCollection 2017.

42.

Effects of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in the Treatment of Goblet Cell Carcinoma: A Prospective Cohort Study.

Madsen AH, Ladekarl M, Villadsen GE, Grønbæk H, Sørensen MM, Stribolt K, Verwaal VJ, Iversen LH.

Ann Surg Oncol. 2018 Feb;25(2):422-430. doi: 10.1245/s10434-017-6272-x. Epub 2017 Dec 6.

PMID:
29214450
43.

Time course of compromised urea synthesis in patients with alcoholic hepatitis.

Glavind E, Aagaard NK, Gronbaek H, Orntoft NW, Vilstrup H, Thomsen KL.

Scand J Gastroenterol. 2018 May;53(5):592-597. doi: 10.1080/00365521.2017.1399163. Epub 2017 Nov 7.

PMID:
29113530
44.

Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.

Ali AS, Grönberg M, Federspiel B, Scoazec JY, Hjortland GO, Grønbæk H, Ladekarl M, Langer SW, Welin S, Vestermark LW, Arola J, Österlund P, Knigge U, Sorbye H, Grimelius L, Janson ET.

PLoS One. 2017 Nov 7;12(11):e0187667. doi: 10.1371/journal.pone.0187667. eCollection 2017.

45.

Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.

Ferolla P, Brizzi MP, Meyer T, Mansoor W, Mazieres J, Do Cao C, Léna H, Berruti A, Damiano V, Buikhuisen W, Grønbæk H, Lombard-Bohas C, Grohé C, Minotti V, Tiseo M, De Castro J, Reed N, Gislimberti G, Singh N, Stankovic M, Öberg K, Baudin E.

Lancet Oncol. 2017 Dec;18(12):1652-1664. doi: 10.1016/S1470-2045(17)30681-2. Epub 2017 Oct 23.

PMID:
29074099
46.

Cell death markers in patients with cirrhosis and acute decompensation.

Macdonald S, Andreola F, Bachtiger P, Amoros A, Pavesi M, Mookerjee R, Zheng YB, Gronbaek H, Gerbes AL, Sola E, Caraceni P, Moreau R, Gines P, Arroyo V, Jalan R.

Hepatology. 2018 Mar;67(3):989-1002. doi: 10.1002/hep.29581. Epub 2018 Jan 24.

47.

[Acute-on-chronic liver failure].

Ørntoft NW, Thomsen KL, Dam G, Aagaard NK, Grønbæk H.

Ugeskr Laeger. 2017 Sep 18;179(38). pii: V04170301. Review. Danish.

PMID:
28918795
48.

Subjective evaluation of psychosocial well-being in children and youths with overweight or obesity: the impact of multidisciplinary obesity treatment.

Fonvig CE, Hamann SA, Nielsen TRH, Johansen MØ, Grønbæk HN, Mollerup PM, Holm JC.

Qual Life Res. 2017 Dec;26(12):3279-3288. doi: 10.1007/s11136-017-1667-5. Epub 2017 Jul 31.

PMID:
28762099
49.

Effects of lifestyle intervention on soluble CD163, a macrophage activation marker, in patients with non-alcoholic fatty liver disease.

Rødgaard-Hansen S, St George A, Kazankov K, Bauman A, George J, Grønbæk H, Jon Møller H.

Scand J Clin Lab Invest. 2017 Nov;77(7):498-504. doi: 10.1080/00365513.2017.1346823. Epub 2017 Jul 17.

PMID:
28715286
50.

[Non-alcoholic fatty liver disease in children and adolescents].

Björklund J, Laursen TL, Kazankov K, Thomsen KL, Hamilton-Dutoit S, Stenbøg E, Grønbæk H.

Ugeskr Laeger. 2017 Jul 3;179(27). pii: V11160796. Review. Danish.

PMID:
28689548

Supplemental Content

Loading ...
Support Center